Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSSR 3306 is a pan-JNK inhibitor (IC50s = 67, 283, and 159 nM for JNK1, JNK2, and JNK3, respectively).1 It is selective for JNK1-3 over p38 MAPK (IC50 = >20 µM). SR 3306 (300-1,000 nM) reduces cell death induced by N-methyl-4-phenylpyridinium (MPP+) in primary rat mesencephalic dopaminergic neurons. It reduces MPTP- or 6-OHDA-induced neurodegeneration of dopaminergic neurons in the mouse substantia nigra pars compacta.1,2 SR 3306 (10 mg/kg) decreases D-amphetamine-induced circling in rats in a 6-OHDA model of Parkinson’s disease.2 It also enhances leptin-induced STAT3 activation in the hypothalamus, reduces food intake, decreases body weight in diet-induced obese (DIO) mice when administered at a dose of 30 mg/kg.3
WARNING This product is not for human or veterinary use.
1. Small molecule c-
2. JNK Inhibition protects dopamine neurons and provides behavioral improvement in a rat 6-
3. Pharmacological inhibition of c-